Sirtuin 7 ameliorates cuproptosis, myocardial remodeling and heart dysfunction in hypertension through the modulation of YAP/ATP7A signaling
Apoptosis · 2024-12 · 29 (11-12) · 2161-2182
DOI: 10.1007/s10495-024-02021-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apoptosis, online erschienen am 11.10.2024. Verfasst von Yu-Fei Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center and Beijing Key Laboratory of Hypertension, Beijing Institute of Respiratory Medicine and Beijing Chaoyang Hospital, Capital Medical Uni…. Hauptthemen laut MEDLINE: Hypertension, Sirtuins, Rats, Inbred SHR, Signal Transduction. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: General Program and the National Major Research Plan Training Program of the National Natural Science Foundation of China, Beijing Natural Science Foundation, Clinical Research Incubation Program of Beijing Chaoyang Hospital Affiliated to Capital Medical University.
Abstract (Originalsprache)
Myocardial fibrosis is a typical pathological manifestation of hypertension. However, the exact role of sirtuin 7 (SIRT7) in myocardial remodeling remains largely unclear. Here, spontaneously hypertensive rats (SHRs) and angiotensin (Ang) II-induced hypertensive mice were pretreated with recombinant adeno-associated virus (rAAV)-SIRT7, copper chelator tetrathiomolybdate (TTM) or copper ionophore elesclomol, respectively. Compared with normotensive controls, reduced SIRT7 expression and augmented cuproptosis were observed in hearts of hypertensive rats and mice with decreased FDX1 levels and increased HSP70 levels. Notably, intervention with rAAV-SIRT7 and TTM strikingly prevented DLAT oligomers aggregation, and elevated ATP7A and TOM20 expressions, contributing to the alleviation of cuproptosis, mitochondrial injury, myocardial remodeling and heart dysfunction in spontaneously hypertensive rats and Ang II-induced hypertensive mice. In cultured rat primary cardiac fibroblasts (CFs), rhSIRT7 alleviated CuCl2, Ang II or elesclomol-induced cuproptosis and fibroblast activation by blunting DLAT oligomers accumulation and downregulating α-SMA expression. Additionally, conditioned medium from rhSIRT7-pretreated CFs remarkably mitigated cellular hypertrophy and mitochondrial impairments of neonatal rat cardiomyocytes, as well as cell migration and polarization of RAW 264.7 macrophages. Importantly, verteporfin reduced CuCl2-induced cuproptosis, mitochondrial injury and fibrotic activation in CFs. Knockdown of ATP7A with si-ATP7A blocked cellular protective effects of rhSIRT7 and verteporfin in CFs. In conclusion, SIRT7 attenuates cuproptosis, myocardial fibrosis and heart dysfunction in hypertension through the modulation of YAP/ATP7A signaling. Targeting SIRT7 is of vital importance for developing therapeutic strategies in hypertension and hypertensive heart disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart Center and Beijing Key Laboratory of Hypertension, Beijing Institute of Respiratory Medicine and Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
- Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
- Heart Center and Beijing Key Laboratory of Hypertension, Beijing Institute of Respiratory Medicine and Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. jczhong@sina.com.
- Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China. jczhong@sina.com.
ORCID-Profile: Jiu-Chang Zhong
Förderung
- General Program and the National Major Research Plan Training Program of the National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Clinical Research Incubation Program of Beijing Chaoyang Hospital Affiliated to Capital Medical University
- the 2024 Reform and Development Program of Beijing Institute of Respiratory Medicine
Zitieren
APA
Chen, Y. F., Qi, R. Q., Song, J. W., Wang, S. Y., Dong, Z. J., Chen, Y. H., Liu, Y., Zhou, X. Y., Li, J., Liu, X. Y., & Zhong, J. C. (2024). Sirtuin 7 ameliorates cuproptosis, myocardial remodeling and heart dysfunction in hypertension through the modulation of YAP/ATP7A signaling. Apoptosis, 29(11-12), 2161-2182. https://doi.org/10.1007/s10495-024-02021-9
Vancouver
Chen YF, Qi RQ, Song JW, Wang SY, Dong ZJ, Chen YH, et al. Sirtuin 7 ameliorates cuproptosis, myocardial remodeling and heart dysfunction in hypertension through the modulation of YAP/ATP7A signaling. Apoptosis. 2024;29(11-12):2161-2182. doi:10.1007/s10495-024-02021-9
BibTeX
@article{Chen2024,
author = {Chen, Yu-Fei and Qi, Rui-Qiang and Song, Jia-Wei and Wang, Si-Yuan and Dong, Zhao-Jie and Chen, Yi-Hang and Liu, Ying and Zhou, Xin-Yu and Li, Jing and Liu, Xiao-Yan and Zhong, Jiu-Chang},
title = {Sirtuin 7 ameliorates cuproptosis, myocardial remodeling and heart dysfunction in hypertension through the modulation of YAP/ATP7A signaling},
journal = {Apoptosis},
year = {2024},
volume = {29},
number = {11-12},
pages = {2161--2182},
doi = {10.1007/s10495-024-02021-9}
}
EUVIMED